Literature DB >> 29887479

Relationship between QRS duration and incident atrial fibrillation.

Stefanie Aeschbacher1, Wesley T O'Neal2, Philipp Krisai3, Laura Loehr4, Lin Y Chen5, Alvaro Alonso6, Elsayed Z Soliman7, David Conen8.   

Abstract

BACKGROUND: QRS duration (QRSd), a measure of ventricular conduction, has been associated with adverse cardiovascular outcomes, but its relationship with incident atrial fibrillation (AF) is poorly understood. METHODS AND
RESULTS: This study included 15,314 participants from the Atherosclerosis Risk in Communities (ARIC) study who were free of AF at baseline. QRSd was automatically measured from resting 12-lead electrocardiograms (ECGs) at baseline. Incident AF cases were systematically ascertained using ECGs, hospital discharge diagnoses and death certificates. Multivariable adjusted Cox regression analyses were performed to investigate the relationship between QRSd and incident AF. Mean age of our population was 54 ± 6 years (55% females). During a median follow-up of 21.2 years, 2041 confirmed incident AF cases occurred. In multivariable adjusted Cox models, a 1-SD increase in QRSd was associated with a hazard ratio (HR) (95% CI) for AF of 1.05 (1.01; 1.10), p = 0.01. This relationship was significant among women (HR per 1-SD increase in QRSd (95% CI) 1.13 (1.06; 1.20), p < 0.001), but not among men (1.00 (0.95; 1.06), p = 0.97) (p for interaction 0.005). Compared to individuals with a QRSd <100 ms, the HRs for incident AF in individuals with a QRSd of 100-119 and ≥120 ms were 1.13 (1.02; 1.26) and 1.35 (1.08; 1.68), respectively (p for trend 0.002). Again, this relationship was significant among women (p for trend <0.001) but not among men (p for trend 0.23).
CONCLUSION: In this large population-based study, QRSd was an independent predictor of incident AF among women, but not in men. Further studies are needed to better understand the underlying mechanisms.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Atrial fibrillation; Electrocardiogram; Population-based; QRS duration; Sex differences

Mesh:

Year:  2018        PMID: 29887479      PMCID: PMC6027639          DOI: 10.1016/j.ijcard.2018.03.050

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  33 in total

Review 1.  Atrial fibrillation in women: epidemiology, pathophysiology, presentation, and prognosis.

Authors:  Darae Ko; Faisal Rahman; Renate B Schnabel; Xiaoyan Yin; Emelia J Benjamin; Ingrid E Christophersen
Journal:  Nat Rev Cardiol       Date:  2016-04-07       Impact factor: 32.419

2.  Absolute and attributable risks of atrial fibrillation in relation to optimal and borderline risk factors: the Atherosclerosis Risk in Communities (ARIC) study.

Authors:  Rachel R Huxley; Faye L Lopez; Aaron R Folsom; Sunil K Agarwal; Laura R Loehr; Elsayed Z Soliman; Rich Maclehose; Suma Konety; Alvaro Alonso
Journal:  Circulation       Date:  2011-03-28       Impact factor: 29.690

3.  Estrogen receptor alpha up-regulation and redistribution in human heart failure.

Authors:  Shokoufeh Mahmoodzadeh; Sarah Eder; Johannes Nordmeyer; Elisabeth Ehler; Otmar Huber; Peter Martus; Jörg Weiske; Reinhard Pregla; Roland Hetzer; Vera Regitz-Zagrosek
Journal:  FASEB J       Date:  2006-05       Impact factor: 5.191

4.  Predictors of new onset atrial fibrillation during 10-year follow-up after first-ever ischemic stroke.

Authors:  Maria A Baturova; Arne Lindgren; Jonas Carlson; Yuri V Shubik; S Bertil Olsson; Pyotr G Platonov
Journal:  Int J Cardiol       Date:  2015-07-14       Impact factor: 4.164

5.  Electrocardiographic QRS duration and the risk of congestive heart failure: the Framingham Heart Study.

Authors:  Ravi Dhingra; Michael J Pencina; Thomas J Wang; Byung-Ho Nam; Emelia J Benjamin; Daniel Levy; Martin G Larson; William B Kannel; Ralph B D'Agostino; Ramachandran S Vasan
Journal:  Hypertension       Date:  2006-04-03       Impact factor: 10.190

6.  Influence of systolic and diastolic blood pressure on the risk of incident atrial fibrillation in women.

Authors:  David Conen; Usha B Tedrow; Bruce A Koplan; Robert J Glynn; Julie E Buring; Christine M Albert
Journal:  Circulation       Date:  2009-04-13       Impact factor: 29.690

7.  The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators.

Authors: 
Journal:  Am J Epidemiol       Date:  1989-04       Impact factor: 4.897

8.  Association of QRS duration with left ventricular structure and function and risk of heart failure in middle-aged and older adults: the Multi-Ethnic Study of Atherosclerosis (MESA).

Authors:  Leonard Ilkhanoff; Kiang Liu; Hongyan Ning; Saman Nazarian; David A Bluemke; Elsayed Z Soliman; Donald M Lloyd-Jones
Journal:  Eur J Heart Fail       Date:  2012-07-12       Impact factor: 15.534

9.  Sex Differences and Similarities in Atrial Fibrillation Epidemiology, Risk Factors, and Mortality in Community Cohorts: Results From the BiomarCaRE Consortium (Biomarker for Cardiovascular Risk Assessment in Europe).

Authors:  Christina Magnussen; Teemu J Niiranen; Francisco M Ojeda; Francesco Gianfagna; Stefan Blankenberg; Inger Njølstad; Erkki Vartiainen; Susana Sans; Gerard Pasterkamp; Maria Hughes; Simona Costanzo; Maria Benedetta Donati; Pekka Jousilahti; Allan Linneberg; Tarja Palosaari; Giovanni de Gaetano; Martin Bobak; Hester M den Ruijter; Ellisiv Mathiesen; Torben Jørgensen; Stefan Söderberg; Kari Kuulasmaa; Tanja Zeller; Licia Iacoviello; Veikko Salomaa; Renate B Schnabel
Journal:  Circulation       Date:  2017-10-16       Impact factor: 29.690

10.  50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: a cohort study.

Authors:  Renate B Schnabel; Xiaoyan Yin; Philimon Gona; Martin G Larson; Alexa S Beiser; David D McManus; Christopher Newton-Cheh; Steven A Lubitz; Jared W Magnani; Patrick T Ellinor; Sudha Seshadri; Philip A Wolf; Ramachandran S Vasan; Emelia J Benjamin; Daniel Levy
Journal:  Lancet       Date:  2015-05-07       Impact factor: 79.321

View more
  4 in total

1.  Combined Effects of Age and Comorbidities on Electrocardiographic Parameters in a Large Non-Selected Population.

Authors:  Paolo Giovanardi; Cecilia Vernia; Enrico Tincani; Claudio Giberti; Federico Silipo; Andrea Fabbo
Journal:  J Clin Med       Date:  2022-06-28       Impact factor: 4.964

2.  Electrocardiographic QRS duration is influenced by body mass index and sex.

Authors:  Anupam C A Rao; Austin C C Ng; Raymond W Sy; Karin K M Chia; Peter S Hansen; Joseph Chiha; Jens Kilian; Logan B Kanagaratnam
Journal:  Int J Cardiol Heart Vasc       Date:  2021-10-06

3.  Genetic analyses of the electrocardiographic QT interval and its components identify additional loci and pathways.

Authors:  William J Young; Najim Lahrouchi; Aaron Isaacs; ThuyVy Duong; Luisa Foco; Farah Ahmed; Jennifer A Brody; Reem Salman; Raymond Noordam; Jan-Walter Benjamins; Jeffrey Haessler; Leo-Pekka Lyytikäinen; Linda Repetto; Maria Pina Concas; Marten E van den Berg; Stefan Weiss; Antoine R Baldassari; Traci M Bartz; James P Cook; Daniel S Evans; Rebecca Freudling; Oliver Hines; Jonas L Isaksen; Honghuang Lin; Hao Mei; Arden Moscati; Martina Müller-Nurasyid; Casia Nursyifa; Yong Qian; Anne Richmond; Carolina Roselli; Kathleen A Ryan; Eduardo Tarazona-Santos; Sébastien Thériault; Stefan van Duijvenboden; Helen R Warren; Jie Yao; Dania Raza; Stefanie Aeschbacher; Gustav Ahlberg; Alvaro Alonso; Laura Andreasen; Joshua C Bis; Eric Boerwinkle; Archie Campbell; Eulalia Catamo; Massimiliano Cocca; Michael J Cutler; Dawood Darbar; Alessandro De Grandi; Antonio De Luca; Jun Ding; Christina Ellervik; Patrick T Ellinor; Stephan B Felix; Philippe Froguel; Christian Fuchsberger; Martin Gögele; Claus Graff; Mariaelisa Graff; Xiuqing Guo; Torben Hansen; Susan R Heckbert; Paul L Huang; Heikki V Huikuri; Nina Hutri-Kähönen; M Arfan Ikram; Rebecca D Jackson; Juhani Junttila; Maryam Kavousi; Jan A Kors; Thiago P Leal; Rozenn N Lemaitre; Henry J Lin; Lars Lind; Allan Linneberg; Simin Liu; Peter W MacFarlane; Massimo Mangino; Thomas Meitinger; Massimo Mezzavilla; Pashupati P Mishra; Rebecca N Mitchell; Nina Mononen; May E Montasser; Alanna C Morrison; Matthias Nauck; Victor Nauffal; Pau Navarro; Kjell Nikus; Guillaume Pare; Kristen K Patton; Giulia Pelliccione; Alan Pittman; David J Porteous; Peter P Pramstaller; Michael H Preuss; Olli T Raitakari; Alexander P Reiner; Antonio Luiz P Ribeiro; Kenneth M Rice; Lorenz Risch; David Schlessinger; Ulrich Schotten; Claudia Schurmann; Xia Shen; M Benjamin Shoemaker; Gianfranco Sinagra; Moritz F Sinner; Elsayed Z Soliman; Monika Stoll; Konstantin Strauch; Kirill Tarasov; Kent D Taylor; Andrew Tinker; Stella Trompet; André Uitterlinden; Uwe Völker; Henry Völzke; Melanie Waldenberger; Lu-Chen Weng; Eric A Whitsel; James G Wilson; Christy L Avery; David Conen; Adolfo Correa; Francesco Cucca; Marcus Dörr; Sina A Gharib; Giorgia Girotto; Niels Grarup; Caroline Hayward; Yalda Jamshidi; Marjo-Riitta Järvelin; J Wouter Jukema; Stefan Kääb; Mika Kähönen; Jørgen K Kanters; Charles Kooperberg; Terho Lehtimäki; Maria Fernanda Lima-Costa; Yongmei Liu; Ruth J F Loos; Steven A Lubitz; Dennis O Mook-Kanamori; Andrew P Morris; Jeffrey R O'Connell; Morten Salling Olesen; Michele Orini; Sandosh Padmanabhan; Cristian Pattaro; Annette Peters; Bruce M Psaty; Jerome I Rotter; Bruno Stricker; Pim van der Harst; Cornelia M van Duijn; Niek Verweij; James F Wilson; Dan E Arking; Julia Ramirez; Pier D Lambiase; Nona Sotoodehnia; Borbala Mifsud; Christopher Newton-Cheh; Patricia B Munroe
Journal:  Nat Commun       Date:  2022-09-01       Impact factor: 17.694

4.  Trait-associated noncoding variant regions affect TBX3 regulation and cardiac conduction.

Authors:  Jan Hendrik van Weerd; Rajiv A Mohan; Karel van Duijvenboden; Ingeborg B Hooijkaas; Vincent Wakker; Bastiaan J Boukens; Phil Barnett; Vincent M Christoffels
Journal:  Elife       Date:  2020-07-16       Impact factor: 8.140

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.